Other
Evaluation Group
Evaluation Group is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Phase Distribution
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
completed125%
unknown250%
not_yet_recruiting125%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruiting
Reliability and Validity of the Turkish Version of the SCIPI
NCT06990243
unknownnot_applicable
Sarcopenia Screening in Elderly Individuals
NCT06012422
unknown
A Six Minute Walking Test Based Index as an Outcome Predictor in COPD Subjects. (Chronic Obstructive Pulmonary Disease)
NCT03799263
completed
BlueSync Field Evaluation
NCT03518658
Clinical Trials (4)
Showing 4 of 4 trials
NCT06990243
Reliability and Validity of the Turkish Version of the SCIPI
NCT06012422Not Applicable
Sarcopenia Screening in Elderly Individuals
NCT03799263
A Six Minute Walking Test Based Index as an Outcome Predictor in COPD Subjects. (Chronic Obstructive Pulmonary Disease)
NCT03518658
BlueSync Field Evaluation
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4